Skip to main content
ImmuneCited

Omega-3 Fatty Acids (EPA/DHA) के लिए Chronic Inflammation

A

The VITAL trial and multiple randomized controlled trials demonstrate omega-3 fatty acids may help reduce CRP and modulate inflammatory cytokines. DHA showed stronger anti-inflammatory effects than EPA, lowering 4 pro-inflammatory proteins versus 1 in a randomized study.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

The VITAL trial and multiple randomized controlled trials demonstrate omega-3 fatty acids may help reduce CRP and modulate inflammatory cytokines. DHA showed stronger anti-inflammatory effects than EPA, lowering 4 pro-inflammatory proteins versus 1 in a randomized study.

Key Study Findings

Review
Immunosenescence and inflammaging: Mechanisms and modulation through diet and lifestyle.
Dose: None बनाम: None Outcome: Immunosenescence and inflammaging modulation प्रभाव: None None

जनसंख्या: Aging adults (review)

Observational Study n=21 4 weeks Single-blind
Associations between omega-3 fatty acid-derived lipid mediators and markers of inflammation in older subjects with …
Dose: None बनाम: None Outcome: Associations between omega-3 SPMs and inflammatory markers प्रभाव: None None

जनसंख्या: Older adults with low-grade chronic inflammation (CRP>2)

Review
The Impact of Flavonoids and Omega-3 in Mitigating Frailty Syndrome to Improve Treatment Outcomes in …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Review of flavonoids and omega-3 in PAD with frailty

Review
Proresolving Lipid Mediators in the Respiratory System.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Review
Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches.
Dose: None बनाम: None Outcome: Sarcopenia progression and muscle function प्रभाव: None None

जनसंख्या: Older adults with sarcopenia (review)

Review
Immunomodulatory Effects of Omega-3 Fatty Acids: Mechanistic Insights and Health Implications.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: review of omega-3 fatty acids' immunomodulatory effects

Key Statistics

30

अध्ययन

30000

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Nutrients 2025 22 उद्धरण
Annual review of … 2025 13 उद्धरण
International immunopharmacology 2023 8 उद्धरण
Toxicology and applied … 2022 20 उद्धरण
Reproductive medicine and … 2020 11 उद्धरण
Prostaglandins, leukotrienes, and … 2018 38 उद्धरण
Frontiers in immunology 2017 74 उद्धरण
European journal of … 2016 102 उद्धरण
Clinical journal of … 2016 4 उद्धरण
Allergology international : … 2015 205 उद्धरण
Prostaglandins & other … 2015 182 उद्धरण
Nutrition research (New … 2013 90 उद्धरण
Acta medica Indonesiana 2011 37 उद्धरण
Journal of the … 2010 11 उद्धरण
Current atherosclerosis reports 2004 464 उद्धरण
Current atherosclerosis reports 2001 2 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
250-500 mg combined EPA/DHA/day
antiinflammatory:
1,000-3,000 mg combined EPA/DHA/day

अधिकतम सीमा: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Positive --
None 4 weeks Positive 21
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --

सेवन का सर्वोत्तम समय: With meals

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Fishy aftertaste and burping
  • Gastrointestinal discomfort (nausea, diarrhea)
  • Increased bleeding risk at high doses
  • Potential LDL cholesterol increase at very high doses

ज्ञात अंतःक्रियाएँ

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive blood pressure lowering)
  • Orlistat (may reduce omega-3 absorption)
  • Cyclosporine (may modify immunosuppressive effects)

सहनीय अधिकतम सेवन: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Omega-3 Fatty Acids (EPA/DHA) help with Chronic Inflammation?
Based on 30 studies with 30,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (EPA/DHA) may support Chronic Inflammation management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Chronic Inflammation?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 30 peer-reviewed studies with 30,000 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Chronic Inflammation

Omega-3 Fatty Acids (EPA/DHA) अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।